Literature DB >> 7912905

Rift Valley fever in rural northern Senegal: human risk factors and potential vectors.

M L Wilson1, L E Chapman, D B Hall, E A Dykstra, K Ba, H G Zeller, M Traore-Lamizana, J P Hervy, K J Linthicum, C J Peters.   

Abstract

To investigate past infection in and transmission of Rift Valley fever (RVF) virus to humans within an endemic focus, we undertook a retrospective cohort study of the seminomadic Peul people living in sub-Saharan northcentral Senegal. Residents of the rural settlement of Yonofere five years of age or older were studied during February-May 1989. Anti-RVF virus IgG was found in blood samples of 22.3% of 273 persons who responded to a standard questionnaire; none had IgM antibodies. Seropositivity was similar for males (25.4%) and females (21.1%), increased markedly with age for both sexes, and varied considerably among compounds (groups of huts) (0-37.5%). Risk factors for past RVF virus infection were nursing sick people, assisting animals during abortions/births, and treating sick animals. In all age groups, odds ratios (ORs) for RVF viral antibody among females who reported treating sick animals were three to six times greater than for those who did not. The ORs for males who reported assisting with animal births/abortions and nursing sick people were approximately five times those for males who did not. Serologic prevalence of RVF viral antibody among sheep averaged 30.1% overall (0.8% IgM), but varied among compounds (0-66.7%) in a manner different from that of humans. The seasonal abundance and relative density of potential mosquito vectors were estimated by monthly samples captured in Centers for Disease Control and Prevention-type traps. Mosquito abundance varied seasonally with rainfall (> 90% captures during four months). Species diversity was large (28 spp.), dominated by Aedes and Culex. Rift Valley fever virus was not isolated from 142 pools of 2,956 unengorged mosquitoes tested, although three other arboviruses were found. Results indicate that RVF is endemic in this region, people are at considerable risk of infection, and that a heretofore unrecognized mode of human infection under nonepizootic conditions may be transmission via contact with infected animals or humans.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7912905     DOI: 10.4269/ajtmh.1994.50.663

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  30 in total

1.  Evaluation of an Indirect Enzyme-Linked Immunosorbent Assay Based on Recombinant Baculovirus-Expressed Rift Valley Fever Virus Nucleoprotein as the Diagnostic Antigen.

Authors:  Bonto Faburay; William C Wilson; Arss Secka; Barbara Drolet; D Scott McVey; Juergen A Richt
Journal:  J Clin Microbiol       Date:  2019-09-24       Impact factor: 5.948

2.  Aerosolized rift valley fever virus causes fatal encephalitis in african green monkeys and common marmosets.

Authors:  Amy L Hartman; Diana S Powell; Laura M Bethel; Amy L Caroline; Richard J Schmid; Tim Oury; Douglas S Reed
Journal:  J Virol       Date:  2013-12-11       Impact factor: 5.103

3.  Planning for Rift Valley fever virus: use of geographical information systems to estimate the human health threat of white-tailed deer (Odocoileus virginianus)-related transmission.

Authors:  Sravan Kakani; A Desirée LaBeaud; Charles H King
Journal:  Geospat Health       Date:  2010-11       Impact factor: 1.212

4.  NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase.

Authors:  Matthias Habjan; Andreas Pichlmair; Richard M Elliott; Anna K Overby; Timo Glatter; Matthias Gstaiger; Giulio Superti-Furga; Hermann Unger; Friedemann Weber
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

5.  An outbreak of Rift Valley fever in Northeastern Kenya, 1997-98.

Authors:  Christopher W Woods; Adam M Karpati; Thomas Grein; Noel McCarthy; Peter Gaturuku; Eric Muchiri; Lee Dunster; Alden Henderson; Ali S Khan; Robert Swanepoel; Isabelle Bonmarin; Louise Martin; Philip Mann; Bonnie L Smoak; Michael Ryan; Thomas G Ksiazek; Ray R Arthur; Andre Ndikuyeze; Naphtali N Agata; Clarence J Peters
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

6.  Molecular biology of rift valley Fever virus.

Authors:  Michele Bouloy; Friedemann Weber
Journal:  Open Virol J       Date:  2010-04-22

7.  Rift Valley fever virus seroprevalence in human rural populations of Gabon.

Authors:  Xavier Pourrut; Dieudonné Nkoghé; Marc Souris; Christophe Paupy; Janusz Paweska; Cindy Padilla; Ghislain Moussavou; Eric M Leroy
Journal:  PLoS Negl Trop Dis       Date:  2010-07-27

Review 8.  Potential effects of Rift Valley fever in the United States.

Authors:  David M Hartley; Jennifer L Rinderknecht; Terry L Nipp; Neville P Clarke; Gary D Snowder
Journal:  Emerg Infect Dis       Date:  2011-08       Impact factor: 6.883

9.  Inter-epidemic transmission of Rift Valley fever in livestock in the Kilombero River Valley, Tanzania: a cross-sectional survey.

Authors:  Robert D Sumaye; Eveline Geubbels; Edgar Mbeyela; Dirk Berkvens
Journal:  PLoS Negl Trop Dis       Date:  2013-08-08

10.  Arbovirus prevalence in mosquitoes, Kenya.

Authors:  A Desiree LaBeaud; Laura J Sutherland; Samuel Muiruri; Eric M Muchiri; Laurie R Gray; Peter A Zimmerman; Amy G Hise; Charles H King
Journal:  Emerg Infect Dis       Date:  2011-02       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.